Liquid biopsies have emerged as a powerful tool in modern medicine, enabling non-invasive detection and monitoring of diseases such as cancer. At the forefront of this revolution are the BD PAXgene ® ...
BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...
The BD P800™ Blood Collection System stands at the forefront of metabolic research, particularly in the context of obesity. Its unique ability to stabilize critical plasma markers has revolutionized ...
Theranos had a lot of bad ideas, but making blood draws smaller and easier wasn’t necessarily one of them. A decade after the now-defunct blood-testing startup emerged from stealth, BD has now claimed ...
New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals With 510(k) clearance from the U.S. Food ...
The US Food and Drug Administration has issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law, including marketing significantly modified versions of ...
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging Becton, Dickinson and Company’s (BD) blood collection device. This initiative to ...
Babson Diagnostics hopes to make real the industry’s long-held dream of bringing quick and thorough blood testing to retail markets and pharmacies—without the use of needles, tubes or trained ...